Evidence map›Paper›PMID 25255738›Full record

ArticleAmerican journal of medical genetics. Part A2014

Update from the 2013 International Neurofibromatosis Conference.

Scott R Plotkin, Anne C Albers, Dusica Babovic-Vuksanovic, Jaishri O Blakeley, Xandra O Breakefield, Courtney M Dunn, D Gareth Evans, Michael J Fisher, Jan M Friedman, Marco Giovannini and 20 more

Abstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. [Eye involvement in neurofibromatosis].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2016
    Review
  6. Article
  7. Reduced dosage of bevacizumab in treatment of vestibular schwannomas in patients with neurofibromatosis type 2.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2015
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Scott R PlotkinDepartment of Neurology and Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Anne C Albers
Dusica Babovic-Vuksanovic
Jaishri O Blakeley
Xandra O Breakefield
Courtney M Dunn
D Gareth Evans
Michael J Fisher
Jan M Friedman
Marco Giovannini
David H Gutmann
Michel Kalamarides
Andrea I McClatchey
Ludwine Messiaen
Helen Morrison
David B Parkinson
Anat O Stemmer-Rachamimov
Catherine D Van Raamsdonk
Vincent M Riccardi
Tena Rosser
Aaron Schindeler
Miriam J Smith
David A Stevenson
Nicole J Ullrich
Thijs van der Vaart
Brian Weiss
Brigitte C Widemann
Yuan Zhu
Annette C Bakker
Alison C Lloyd

Funding

SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI POMEROY, SCOTT LOREN · 1985 to 2015
$26.2M
Children's Tumor Foundation 2016 Neurofibromatosis (NF) ConferenceR13NS084619 · NINDS · CHILDREN'S TUMOR FOUNDATION · PI FISHER, MICHAEL · 2013 to 2016
$63k
Cancer Research UK 11244Cancer Research UK 17135Medical Research Council MR/J012785/1NICHD NIH HHS P30 HD018655NINDS NIH HHS 1R13NS084619-01NINDS NIH HHS R13 NS084619
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease Models, AnimalAnimalsClinical Trials as TopicCongresses as TopicHumansNeurilemmomaNeurofibromatosesResearchSkin Neoplasmsmerlinneurofibromatosis 1neurofibromatosis 2neurofibrominNF1NF2preclinical modelsschwannomatosisSMARCB1tumor suppressor

Identifiers

PMID25255738
PMCPMC4236251

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.